These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 3275100)
1. Quantitative assessment of cerebral blood flow using technetium-99m-hexamethyl-propyleneamine oxime: Part I, Design of a mathematical model. Matsuda H; Oba H; Terada H; Tsuji S; Sumiya H; Shiba K; Seki H; Imai K; Mori H; Hisada K Ann Nucl Med; 1988 May; 2(1):13-9. PubMed ID: 3275100 [TBL] [Abstract][Full Text] [Related]
2. Does the washout phenomenon of Tc-99m HM-PAO correlate to the "filling-in" phenomenon of I-123 IMP with brain SPECT? Hayashida K; Nishimura T; Imakita S; Uehara T Neuroradiology; 1990; 32(3):196-9. PubMed ID: 2215903 [TBL] [Abstract][Full Text] [Related]
3. [Synthesis of hexamethyl propylamine oxime and comparative study of its diastereoisomers]. Tan T; Wang D; Kuang A; He L; Xu P Hua Xi Yi Ke Da Xue Xue Bao; 1991 Mar; 22(1):58-61. PubMed ID: 1774039 [TBL] [Abstract][Full Text] [Related]
4. SPECT with [99mTc]-d,l-hexamethyl-propylene amine oxime (HM-PAO) compared with regional cerebral blood flow measured by PET: effects of linearization. Yonekura Y; Nishizawa S; Mukai T; Fujita T; Fukuyama H; Ishikawa M; Kikuchi H; Konishi J; Andersen AR; Lassen NA J Cereb Blood Flow Metab; 1988 Dec; 8(6):S82-9. PubMed ID: 3263981 [TBL] [Abstract][Full Text] [Related]
5. Tomographic studies of rCBF with 99mTc-HM-PAO SPECT in comparison with PET in patients with primary brain tumors. Langen KJ; Herzog H; Rota E; Roosen N; Wieler H; Kiwit J; Kuwert T; Storch-Becker A; Feinendegen L Neurosurg Rev; 1987; 10(1):23-4. PubMed ID: 3499584 [TBL] [Abstract][Full Text] [Related]
6. Regional brain blood flow in congenital dysphasia: studies with technetium-99m HM-PAO SPECT. Denays R; Tondeur M; Foulon M; Verstraeten F; Ham H; Piepsz A; Noël P J Nucl Med; 1989 Nov; 30(11):1825-9. PubMed ID: 2809746 [TBL] [Abstract][Full Text] [Related]
7. Cerebral and cerebellar uptake of 99mTc-(d,1)-hexamethyl-propyleneamine oxime (HM-PAO) in patients with brain tumor studied by single photon emission computerized tomography. Lindegaard MW; Skretting A; Hager B; Watne K; Lindegaard KF Eur J Nucl Med; 1986; 12(9):417-20. PubMed ID: 3493139 [TBL] [Abstract][Full Text] [Related]
8. Quantitative local cerebral blood flow measurements with technetium-99m HM-PAO: evaluation using multiple radionuclide digital quantitative autoradiography. Lear JL J Nucl Med; 1988 Aug; 29(8):1387-92. PubMed ID: 2841432 [TBL] [Abstract][Full Text] [Related]
9. Initial experience with SPECT of the brain using 99mTc-hexamethyl-propyleneamine oxime (99mTc-HM-PAO). Spreafico G; Cammelli F; Gadola G; Nicola G; Zancaner F; Tonnarelli G; Sala E; Freschi R Eur J Nucl Med; 1987; 12(11):557-9. PubMed ID: 3494608 [TBL] [Abstract][Full Text] [Related]
10. Initial cerebral HM-PAO distribution compared to LCBF: use of a model which considers cerebral HM-PAO trapping kinetics. Lear JL J Cereb Blood Flow Metab; 1988 Dec; 8(6):S31-7. PubMed ID: 3263979 [TBL] [Abstract][Full Text] [Related]
11. Cerebral uptake and retention of 99Tcm-hexamethylpropyleneamine oxime (99Tcm-HM-PAO). Holmes RA; Chaplin SB; Royston KG; Hoffman TJ; Volkert WA; Nowotnik DP; Canning LR; Cumming SA; Harrison RC; Higley B Nucl Med Commun; 1985 Aug; 6(8):443-7. PubMed ID: 3877890 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of vasospasm secondary to subarachnoid hemorrhage with technetium-99m-hexamethyl-propyleneamine oxime (HM-PAO) tomoscintigraphy. Soucy JP; McNamara D; Mohr G; Lamoureux F; Lamoureux J; Danais S J Nucl Med; 1990 Jun; 31(6):972-7. PubMed ID: 2348242 [TBL] [Abstract][Full Text] [Related]
13. Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. Neirinckx RD; Canning LR; Piper IM; Nowotnik DP; Pickett RD; Holmes RA; Volkert WA; Forster AM; Weisner PS; Marriott JA J Nucl Med; 1987 Feb; 28(2):191-202. PubMed ID: 3492596 [TBL] [Abstract][Full Text] [Related]
14. Linearization correction of 99mTc-labeled hexamethyl-propylene amine oxime (HM-PAO) image in terms of regional CBF distribution: comparison to C15O2 inhalation steady-state method measured by positron emission tomography. Inugami A; Kanno I; Uemura K; Shishido F; Murakami M; Tomura N; Fujita H; Higano S J Cereb Blood Flow Metab; 1988 Dec; 8(6):S52-60. PubMed ID: 3142888 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of cerebral collateral circulation by technetium-99m HM-PAO brain SPECT during Matas test: report of three cases. Matsuda H; Higashi S; Asli IN; Eftekhari M; Esmaili J; Seki H; Tsuji S; Oba H; Imai K; Terada H J Nucl Med; 1988 Oct; 29(10):1724-9. PubMed ID: 3262729 [TBL] [Abstract][Full Text] [Related]
16. Blood flow imaging of a posterior circulation stroke. Use of technetium Tc 99m hexamethylpropyleneamine oxime and single photon emission computed tomography. Foster NL; Mountz JM; Bluelein LA; Ackermann RJ; Petry NA; Kuhl DE Arch Neurol; 1988 Jun; 45(6):687-90. PubMed ID: 3259422 [TBL] [Abstract][Full Text] [Related]
17. Clinical use of technetium-99m HM-PAO for determination of brain death. Reid RH; Gulenchyn KY; Ballinger JR J Nucl Med; 1989 Oct; 30(10):1621-6. PubMed ID: 2795202 [TBL] [Abstract][Full Text] [Related]
18. Assessment of 99mTc-HM-PAO parameters with SPECT for improved evaluation of blood flow in cerebral lesions. Bartolini A; Gasparetto B; Albano C; Ajmar G; Primavera A; Roncallo F Comput Med Imaging Graph; 1991; 15(5):303-9. PubMed ID: 1756448 [TBL] [Abstract][Full Text] [Related]
19. Thalamic syndrome and cortical hypoperfusion on technetium-99m HM-PAO brain SPECT. Lee MS; Choi IS; Chung TS Yonsei Med J; 1989; 30(2):151-7. PubMed ID: 2800565 [TBL] [Abstract][Full Text] [Related]
20. Quantitative measurements of cerebral blood flow using SPECT and [99mTc]-d,l-HM-PAO compared to xenon-133. Andersen AR; Friberg HH; Schmidt JF; Hasselbalch SG J Cereb Blood Flow Metab; 1988 Dec; 8(6):S69-81. PubMed ID: 3263980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]